May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Topically Applied Leptin Accumulates in the Hypothalamus of Lewis Rats
Author Affiliations & Notes
  • J.Y. Lee
    Biomedical Science and Disease, New England College of Optometry, Boston, MA
  • P. Mayo
    Biomedical Science and Disease, New England College of Optometry, Boston, MA
  • C. Robinson
    Biomedical Science and Disease, New England College of Optometry, Boston, MA
  • S.B. Koevary
    Biomedical Science and Disease, New England College of Optometry, Boston, MA
  • Footnotes
    Commercial Relationships  J.Y. Lee, None; P. Mayo, None; C. Robinson, None; S.B. Koevary, None.
  • Footnotes
    Support  NEI R24 EY014817 HIGHWIRE EXLINK_ID="47:5:5091:1" VALUE="EY014817" TYPEGUESS="GEN" /HIGHWIRE ; Massachusetts Lions Eye Research Fund
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 5091. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J.Y. Lee, P. Mayo, C. Robinson, S.B. Koevary; Topically Applied Leptin Accumulates in the Hypothalamus of Lewis Rats . Invest. Ophthalmol. Vis. Sci. 2006;47(13):5091.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : It has been suggested that blood–brain–barrier (BBB) resistance to leptin, a peptide that plays an important role in the hypothalamic regulation of appetite, is responsible, in part, for diet–induced obesity. We previously reported that topically applied leptin could accumulate in the CSF, suggesting that such an approach might be efficacious in bypassing the BBB. In this study, we specifically quantified leptin levels in the hypothalamus following topical leptin administration.

Methods: : A 10 microliter drop of a 1.25 mg/ml solution of leptin in 1% saponin was applied to the eyes of fasted, Lewis rats; untreated fasted rats served as controls. The hypothalamus from these animals was harvested 20 minutes later, homogenized, and their supernatants assessed for the presence of leptin using an ELISA assay; results (mean+SE) are expressed as pg of leptin/mg protein (the protein content of the tissue pellets was determined using the Lowry method). To control for the effects of systemically absorbed leptin, a separate cohort of rats was subcutaneously injected with leptin (19 micrograms/rat) and their hypothalamic leptin levels determined after 30 minutes.

Results: : Animals treated with leptin eye drops displayed significantly elevated levels of this peptide in the hypothalamus. While baseline values were 22.5+2.9, levels rose to 33.8+3.1 after 20 minutes (p<0.03) in treated animals; serum leptin levels (mean+SE), measured in pg/ml, in these animals were 1698+392 and 2360+794, respectively (not significant, p=0.5). Though serum leptin levels in leptin–injected rats rose 7 fold over controls in leptin–injected rats (p<0.005), their hypothalamic levels were not significantly elevated (42.3+6.8 vs. 30+4.6, p=0.18).

Conclusions: : Our results showed that leptin accumulated in the hypothalamus following topical delivery, supporting the contention that this approach should be investigated further to determine its effectiveness for the treatment of diet–induced obesity.

Keywords: drug toxicity/drug effects • pharmacology • neuropeptides 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×